Literature DB >> 23693158

Cytokine synergy: an underappreciated contributor to innate anti-viral immunity.

Eric Bartee1, Grant McFadden.   

Abstract

Inflammatory cytokines, such as tumor necrosis factor and the members of the interferon family, are potent mediators of the innate anti-viral immune response. The intracellular anti-viral states resulting from treatment of cultured cells with each of these molecules independently has been well studied; but, within complex tissues, the early inflammatory response is likely mediated by simultaneously expressed mixtures of these, and other, protective anti-viral cytokines. Such cytokine mixtures have been shown to induce potently synergistic anti-viral responses in vitro which are more complex than the simple summation of the individual cytokine response profiles. The physiological role of this 'cytokine synergy', however, remains largely unappreciated in vivo. This brief commentary will attempt to summarize the potential effects and mechanisms of anti-viral cytokine synergy as well as present several 'real-world' applications where this phenomenon might play an important role.
Copyright © 2013 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Anti-viral immunity; Cytokine synergy; Innate immunity; Interferon; TNF

Mesh:

Substances:

Year:  2013        PMID: 23693158      PMCID: PMC3748162          DOI: 10.1016/j.cyto.2013.04.036

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  40 in total

1.  The in vitro antiviral activity of tumor necrosis factor (TNF) in WISH cells is mediated by IFN-beta induction.

Authors:  V Ruggiero; G Antonelli; G Conciatori; M Gentile; J Van Damme; F Dianzani
Journal:  Antiviral Res       Date:  1989-03       Impact factor: 5.970

2.  Antiviral activity of tumour necrosis factor. Synergism with interferons and induction of oligo-2',5'-adenylate synthetase.

Authors:  J Mestan; M Brockhaus; H Kirchner; H Jacobsen
Journal:  J Gen Virol       Date:  1988-12       Impact factor: 3.891

3.  Influence of input multiplicity of infection on the antiviral activity of interferon.

Authors:  L Stitz; H Schellekens
Journal:  J Gen Virol       Date:  1980-01       Impact factor: 3.891

4.  Interferon-gamma enhances expression of cellular receptors for tumor necrosis factor.

Authors:  M Tsujimoto; Y K Yip; J Vilcek
Journal:  J Immunol       Date:  1986-04-01       Impact factor: 5.422

5.  Induction of the synthesis of tumor necrosis factor receptors by interferon-gamma.

Authors:  V Ruggiero; J Tavernier; W Fiers; C Baglioni
Journal:  J Immunol       Date:  1986-04-01       Impact factor: 5.422

6.  Human gamma interferon and tumor necrosis factor exert a synergistic blockade on the replication of herpes simplex virus.

Authors:  E Feduchi; M A Alonso; L Carrasco
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

7.  Synergistic inhibition of Epstein-Barr virus: transformation of B lymphocytes by alpha and gamma interferon and by 3'-azido-3'-deoxythymidine.

Authors:  J C Lin; Z X Zhang; T C Chou; I Sim; J S Pagano
Journal:  J Infect Dis       Date:  1989-02       Impact factor: 5.226

Review 8.  Immune responses to myxoma virus.

Authors:  Peter Kerr; Grant McFadden
Journal:  Viral Immunol       Date:  2002       Impact factor: 2.257

9.  Tumour necrosis factors alpha and beta inhibit virus replication and synergize with interferons.

Authors:  G H Wong; D V Goeddel
Journal:  Nature       Date:  1986 Oct 30-Nov 5       Impact factor: 49.962

10.  Evolutionary history and attenuation of myxoma virus on two continents.

Authors:  Peter J Kerr; Elodie Ghedin; Jay V DePasse; Adam Fitch; Isabella M Cattadori; Peter J Hudson; David C Tscharke; Andrew F Read; Edward C Holmes
Journal:  PLoS Pathog       Date:  2012-10-04       Impact factor: 6.823

View more
  26 in total

1.  Kinetic Differences and Synergistic Antiviral Effects Between Type I and Type III Interferon Signaling Indicate Pathway Independence.

Authors:  Emily A Voigt; John Yin
Journal:  J Interferon Cytokine Res       Date:  2015-05-04       Impact factor: 2.607

2.  Prothymosin α variants isolated from CD8+ T cells and cervicovaginal fluid suppress HIV-1 replication through type I interferon induction.

Authors:  Avelino Teixeira; Benjamin Yen; Gabriele Luca Gusella; Albert G Thomas; Michael P Mullen; Judith Aberg; Xintong Chen; Yujin Hoshida; Harm van Bakel; Eric Schadt; Christopher F Basler; Adolfo García-Sastre; Arevik Mosoian
Journal:  J Infect Dis       Date:  2014-11-17       Impact factor: 5.226

Review 3.  Pathogenic role of cytokines in COVID-19, its association with contributing co-morbidities and possible therapeutic regimens.

Authors:  Ayesha Tanveer; Bushra Akhtar; Ali Sharif; Uzma Saleem; Azhar Rasul; Aftab Ahmad; Kashif Jilani
Journal:  Inflammopharmacology       Date:  2022-08-10       Impact factor: 5.093

Review 4.  Cytokines in immune-mediated inflammatory myopathies: cellular sources, multiple actions and therapeutic implications.

Authors:  E M Moran; F L Mastaglia
Journal:  Clin Exp Immunol       Date:  2014-12       Impact factor: 4.330

5.  Constitutive IFNα/β signaling maintains expression of signaling intermediaries for efficient cytokine responses.

Authors:  Nicole L Messina; Christopher J P Clarke; Ricky W Johnstone
Journal:  JAKSTAT       Date:  2016-05-18

6.  Tumor Necrosis Factor Inhibits Spread of Hepatitis C Virus Among Liver Cells, Independent From Interferons.

Authors:  Stephen M Laidlaw; Svetlana Marukian; Rachel H Gilmore; Siobhán B Cashman; Volodymyr Nechyporuk-Zloy; Charles M Rice; Lynn B Dustin
Journal:  Gastroenterology       Date:  2017-04-26       Impact factor: 22.682

7.  Association between Prediagnostic Allergy-Related Serum Cytokines and Glioma.

Authors:  Judith Schwartzbaum; Michal Seweryn; Christopher Holloman; Randall Harris; Samuel K Handelman; Grzegorz A Rempala; Ruo-Pan Huang; Brett Burkholder; Adam Brandemihl; Henrik Kallberg; Tom Borge Johannesen; Anders Ahlbom; Maria Feychting; Tom K Grimsrud
Journal:  PLoS One       Date:  2015-09-09       Impact factor: 3.240

8.  Investigating the Role of TNF-α and IFN-γ Activation on the Dynamics of iNOS Gene Expression in LPS Stimulated Macrophages.

Authors:  Taha Salim; Cheryl L Sershen; Elebeoba E May
Journal:  PLoS One       Date:  2016-06-08       Impact factor: 3.240

9.  Type 1 diabetes alters lipid handling and metabolism in human fibroblasts and peripheral blood mononuclear cells.

Authors:  Albert R Jones; Emily L Coleman; Nicholas R Husni; Jude T Deeney; Forum Raval; Devin Steenkamp; Hans Dooms; Barbara S Nikolajczyk; Barbara E Corkey
Journal:  PLoS One       Date:  2017-12-04       Impact factor: 3.240

10.  Turning the tables on cytomegalovirus: targeting viral Fc receptors by CARs containing mutated CH2-CH3 IgG spacer domains.

Authors:  Julia Proff; Charlotte U Brey; Armin Ensser; Wolfgang Holter; Manfred Lehner
Journal:  J Transl Med       Date:  2018-02-08       Impact factor: 8.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.